Sector revisions Ipsen

Stocks

Market Closed - Euronext Paris 19:55:00 09/09/2026 +04			5-day change	1st Jan Change
158.50 ^EUR	-0.44%		-5.49%	+33.19%

09-08	Rubis posts gold-standard results, telecom operators talk, Novartis has to pull the parachute.
08-21	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	IPSEN							15
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							22
	AMGEN INC.							29
	NOVO NORDISK A/S							23
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	SANOFI							23
	GSK PLC							21
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							22
	Weighted average by Cap.							25

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!